Cargando…
Mapping the Serum Proteome of COVID-19 Patients; Guidance for Severity Assessment
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), whose outbreak in 2019 led to an ongoing pandemic with devastating consequences for the global economy and human health. According to the World Health Organization, COVID-19 has affected mo...
Autores principales: | Nuñez, Estefanía, Orera, Irene, Carmona-Rodríguez, Lorena, Paño, José Ramón, Vázquez, Jesús, Corrales, Fernando J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313396/ https://www.ncbi.nlm.nih.gov/pubmed/35884998 http://dx.doi.org/10.3390/biomedicines10071690 |
Ejemplares similares
-
A Proteomic Approach for Systematic Mapping of Substrates of Human Deubiquitinating Enzymes
por: Ramirez, Juanma, et al.
Publicado: (2021) -
Serum lipid mediator profiles in COVID-19 patients and lung disease severity: a pilot study
por: Irún, Pilar, et al.
Publicado: (2023) -
Analysis of Serum Proteome after Treatment of Osteoporosis with Anabolic or Antiresorptive Drugs
por: del Real, Alvaro, et al.
Publicado: (2022) -
Quantitative proteomic analysis of serum-purified exosomes identifies putative pre-eclampsia-associated biomarkers
por: Navajas, Rosana, et al.
Publicado: (2022) -
Mapping the serum proteome to neurological diseases using whole genome sequencing
por: Png, Grace, et al.
Publicado: (2021)